Conan MedTech
Conan MedTech is a pioneering company in concussion detection and care, developing advanced, real-time diagnostic solutions utilizing saliva biomarkers. Their mission is to revolutionize concussion diagnosis with innovative, portable, and non-invasive medical devices, aiming to improve patient outcomes and safety across sports, military, and educational sectors.
Industries
Nr. of Employees
small (1-50)
Products
Saliva-based point-of-care lateral flow concussion diagnostic
A portable lateral flow immunoassay designed to detect a salivary biomarker associated with mild traumatic brain injury, intended for rapid, non-invasive point-of-care use with a mobile reader application.
Saliva-based point-of-care lateral flow concussion diagnostic
A portable lateral flow immunoassay designed to detect a salivary biomarker associated with mild traumatic brain injury, intended for rapid, non-invasive point-of-care use with a mobile reader application.
Services
Design and execution of clinical studies, protocol development, IRB coordination, site management, data collection, and statistical reporting.
End-to-end product lifecycle management for lateral flow assays including design, manufacturing oversight, quality control, distribution planning, and risk management.
Development and testing of a mobile reader application integrated with diagnostic assays for point-of-care readout and user workflows.
Collaboration with contract research organizations for research, assay development, manufacturing operations, and execution of clinical studies.
Design and execution of clinical studies, protocol development, IRB coordination, site management, data collection, and statistical reporting.
End-to-end product lifecycle management for lateral flow assays including design, manufacturing oversight, quality control, distribution planning, and risk management.
Development and testing of a mobile reader application integrated with diagnostic assays for point-of-care readout and user workflows.
Collaboration with contract research organizations for research, assay development, manufacturing operations, and execution of clinical studies.
Expertise Areas
- Concussion and mTBI diagnostics
- Lateral flow assay development
- Monoclonal antibody development for diagnostics
- Point-of-care diagnostic device integration
Key Technologies
- Lateral flow immunoassay
- Monoclonal antibody production
- Salivary biomarker assays
- Point-of-care diagnostic devices
News & Updates
Since 2019, Conan MedTech has sought to transform the market for concussion diagnosis. Bayan Alturkestani's innovative approach earned her recognition as Brain Injury MedTech CEO of the Year in 2023.
Bayan Alturkestani was recognized as a 2023 recipient for her groundbreaking concussion detection technology during her time at Temple University.
Won the first place at the Saudi Basic Industries Corporation entrepreneurship competition in Washington, D.C., in 2019.
Selected as a finalist and winner of the Lori Hermelin Bush Seed Fund at Temple University in 2019, supporting innovative ventures.
Since 2019, Conan MedTech has sought to transform the market for concussion diagnosis. Bayan Alturkestani's innovative approach earned her recognition as Brain Injury MedTech CEO of the Year in 2023.
Bayan Alturkestani was recognized as a 2023 recipient for her groundbreaking concussion detection technology during her time at Temple University.
Won the first place at the Saudi Basic Industries Corporation entrepreneurship competition in Washington, D.C., in 2019.
Selected as a finalist and winner of the Lori Hermelin Bush Seed Fund at Temple University in 2019, supporting innovative ventures.